Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components
  2. Nilsson, Monique B.; Sun, Huiying; Robichaux, Jacqulyne; Pfeifer, Matthias; McDermott, Ultan; Travers, Jon; Diao, Lixia; Xi, Yuanxin; Tong, Pan; Shen, Li; Hofstad, Mia; Kawakami, Masanori; Le, Xiuning; Liu, Xi; Fan, Youhong; Poteete, Alissa; Hu, Limei; Negrao, Marcelo; Tran, Hai; Dmitrovsky, Ethan; Peng, David; Gibbons, Don L.; Wang, Jing; Heymach, John
  3. SCIENCE TRANSLATIONAL MEDICINE. 2020, SEP 2; 12(559): pii: aaz4589.
  1. 2.   Sprouty2 regulates positioning of retinal progenitors through suppressing the Ras/Raf/MAPK pathway
  2. Sun,Jian; Yoon,Jaeho; Lee,Moonsup; Hwang,Rich Yooseok; Daar,Ira
  3. Scientific reports. 2020, Aug 13; 10(1): 13752.
  1. 3.   Slug and E-Cadherin: Stealth Accomplices?
  2. Sterneck,Esta; Poria,Dipak; Kuppusamy,Balamurugan
  3. Frontiers in molecular biosciences. 2020, JUL 14; 7: 138.
  1. 4.   TIMP-2 suppresses tumor growth and metastasis in murine model of triple-negative breast cancer
  2. Peeney, David; Jensen, Sandra M; Castro, Nadia P; Kumar, Sarvesh; Noonan, Sylvia; Handler, Chenchen; Kuznetsov, Alex; Shih, Joanna; Tran, Andy D; Salomon,David; Stetler-Stevenson, William G
  3. Carcinogenesis. 2020, MAR; 41(3): 313-325.
  1. 5.   A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer
  2. Gatti-Mays, Margaret E; Redman, Jason M; Donahue, Renee N; Palena, Claudia; Madan, Ravi A; Karzai, Fatima; Bilusic, Marijo; Sater, Houssein Abdul; Marté, Jennifer L; Cordes, Lisa M; McMahon, Sheri; Steinberg, Seth M; Orpia,Alanvin; Burmeister, Andrea; Schlom, Jeffrey; Gulley, James L; Strauss, Julius
  3. The oncologist. 2019, Oct 08; pii: theoncologist.2019-0608..
  1. 6.   Epigenetic re-wiring of breast cancer by pharmacological targeting of C-terminal binding protein
  2. Byun, Jung S; Park, Samson; Yi, Dae Ik; Shin, Jee-Hye; Hernandez, Sara Gil; Hewitt, Stephen M; Nicklaus,Marc; Peach,Megan; Guasch, Laura; Tang, Binwu; Wakefield, Lalage M; Yan, Tingfen; Caban, Ambar; Jones, Alana; Kabbout, Mohamed; Vohra, Nasreen; Nápoles, Anna María; Singhal, Sandeep; Yancey, Ryan; De Siervi, Adriana; Gardner, Kevin
  3. Cell death & disease. 2019, Sep 18; 10(10): 689.
  1. 7.   Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells
  2. Marusiak, Anna A.; Prelowska, Monika K.; Mehlich, Dawid; Lazniewski, Michal; Kaminska, Klaudia; Gorczynski, Adam; Korwat, Aleksandra; Sokolowska, Olga; Kedzierska, Hanna; Golab, Jakub; Biernat, Wojciech; Plewczynski, Dariusz; Brognard,John; Nowis, Dominika
  3. Oncogene. 2019, Apr 11; 38(15): 2860-2875.
  1. 8.   Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells
  2. Yao, X. H.; Liu, Y.; Chen, K. Q.; Gong, W. H.; Liu, M. Y.; Bian, X. W.; Wang, J. M.
  3. International Immunopharmacology. 2011, Dec; 11(12): 1961-1966.
  1. 9.   The cancer stem cell niche-there goes the neighborhood?
  2. Cabarcas, S. M.; Mathews, L. A.; Farrar, W. L.
  3. International Journal of Cancer. 2011, Nov; 129(10): 2315-2327.
  1. 10.   Increased Expression of DNA Repair Genes in Invasive Human Pancreatic Cancer Cells
  2. Mathews, L. A.; Cabarcas, S. M.; Hurt, E. M.; Zhang, X. H.; Jaffee, E. M.; Farrar, W. L.
  3. Pancreas. 2011, Jul; 40(5): 730-739.
  1. 11.   DNA repair: the culprit for tumor-initiating cell survival?
  2. Mathews, L. A.; Cabarcas, S. M.; Farrar, W. L.
  3. Cancer and Metastasis Reviews. 2011, Jun; 30(2): 185-197.
  1. 12.   Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer
  2. Crea, F.; Hurt, E. M.; Mathews, L. A.; Cabarcas, S. M.; Sun, L.; Marquez, V. E.; Danesi, R.; Farrar, W. L.
  3. Molecular Cancer. 2011, Apr; 10: 10.
  1. 13.   Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells
  2. Mathews, L. A.; Hurt, E. M.; Zhang, X. H.; Farrar, W. L.
  3. Molecular Cancer. 2010, Oct; 9: 17.
  1. 14.   Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature
  2. Klarmann, G. J.; Hurt, E. M.; Mathews, L. A.; Zhang, X. H.; Duhagon, M. A.; Mistree, T.; Thomas, S. B.; Farrar, W. L.
  3. Clinical & Experimental Metastasis. 2009 26(5): 433-446.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel